Biomaterials Market

Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural), Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2025

Report Code: BT 1556 Jan, 2021, by marketsandmarkets.com

[298 Pages Report] The global biomaterials market size is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period. Biomaterials market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine. In addition, high growth is expected for plastic surgery and wound healing applications, which will further drive the growth of the biomaterials market in the coming years.

Biomaterials Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the biomaterials market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic. With the World Health Organization (WHO) officially declaring the outbreak of COVID-19 a pandemic, a mix of established pharmaceutical and biopharmaceutical companies, as well as small startups, have stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus.

The coronavirus outbreak disrupted business and economic activities globally in the first quarter of 2020. For instance, Aesthetic procedures, which mainly constitute cosmetic surgeries (like breast implantation and lipoplasty) and non-essential dental procedures, have been delayed due to the COVID-19 crisis. Moreover, From March to June 2020, the health system in the US experienced a significant decline in surgical volumes compared with the same period during the previous year. The pandemic had a major impact on the US, Japan, China, as well as many major European countries. Since most of these countries are major manufacturers of biomaterials, the pandemic and nationwide lockdowns have caused a decline in the sales of these products. This, in turn, had a slightly negative impact on the biomaterials market. However, the market is expected to recover in the next one to two years as research for development of rapid COVID-19 detection test using gold nanoparticles will support market growth.

Global Biomaterials Market Dynamics

DRIVER: Increased funds and grants by government bodies and universities for the development of novel biomaterials

The demand for and usage of biomaterials in various medical applications has increased significantly across the globe over the last few years. Several government bodies and universities have extended their help in the form of investments, funds, and grants to promote research on the development of novel biomaterials. For instance, In March 2018, Drexel University granted USD 200,000 to the National Science Foundation for research on how biomaterial-mediated control over macrophage behavior affects biomaterial vascularization.Such research and funding activities are expected to boost the development of innovative biomaterials, thus offering an array of opportunities for the growth of the biomaterials market.

RESTRAINT: Stringent clinical & regulatory processes

ncluding North America, Europe, and Asia, to ensure their quality and efficacy. This is primarily because most biomaterial-based medical devices are implantable. All new biomaterials require proof that they are safe and effective before they can be approved for marketing. In the US, the process for approval follows strict guidelines and regulations set by the FDA. According to the FDA, biomaterial-based products, such as implantable pacemakers, stents, and heart valves, are classified as Class III devices, which pose the highest potential risk of illness or injury. Thus, these devices are subjected to the premarket approval application pathway (the most stringent type of device marketing application).

OPPORTUNITY: Growing healthcare market in emerging economies

The biomaterials market in emerging countries is expected to witness significant growth during the forecast period. This can majorly be attributed to the increasing patient population, rising adoption of implantable devices, growing awareness of CVDs, rising disposable income, improving healthcare infrastructure, and the presence of less-stringent regulatory guidelines (as compared to developed countries) in these countries.

Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies in the world. The World Economic Forum has estimated these emerging economies would account for one-third of the global healthcare expenditure by 2020. The growing demand for surgical procedures, rising geriatric population, and the increasing incidence of target diseases are some of the major factors that are expected to drive the demand for advanced healthcare services and novel medical devices in the respective healthcare systems of these countries. This is expected to offer potential growth opportunities to players operating in the biomaterials market in the coming years.

The metallic biomaterials segment dominated the biomaterials market in 2019.

Based on type, the biomaterials market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials . The Metallic Biomaterials segment accounted for the largest share of the global biomaterials market in 2019. The growing geriatric population globally is expected to drive growth for this segment.

The wound healing segment will witness the highest growth during the forecast period.

Based on application, the biomaterials market is segmented into Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurological/CNS, and Other Applications. In 2019, the wound healing segment is expected to register the highest CAGR during the forecast period. Factors such as growing healthcare infrastructure, increasing diabetic population, vast population pool, in and the increasing healthcare spending will drive market growth.

Biomaterials Market  by Region

North America was the largest regional market for biomaterials in 2019.

Geographically, the biomaterials market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2019, North America accounted for the largest share of the biomaterials market, followed by Europe and the Asia Pacific. The large share of North America in the global market is attributed to the increase in biomaterial-based research, rising demand for plastic surgeries, growing incidence of cancer, and the rising prevalence of cardiovascular diseases.

Key Market Players

Key players in the biomaterials market include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), CoorsTek Inc. (US), CeramTec (Germany), and Gelita AG (Germany).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD Billion)

Segments covered

type, application and region

Geographies covered

North America, Europe, Asia Pacific, and Rest of the World

Companies covered

BASF (Germany), Covestro AG (Germany), Celanese Corporation (Germany), Carpenter Technology (US), Olympus Terumo Biomaterials Corporation (Japan), Evonik Industries (Germany), Xylos Corporation (US), Victrex Plc (UK), Mitsubishi Chemical Holdings Corporation (Japan), GELITA AG (Germany), Corbion (Netherlands), Solvay (US), AB Specialty Silicones (US), CoorsTek (US), CeramTec GmbH (Germany), Royal DSM (Netherlands), The Lubrizol Corporation (US), Berkeley Advanced Biomaterials (US), Zeus Industrial Products, Inc. (US), Noble Biomaterials, Inc. (US), Dimension Inx (US), Artoss, Inc. (US), RDI Group (US), Riton Biomaterial Co., Ltd. (China), Cam Bioceramics (Netherlands)

This report categorizes the biomaterials market into the following segments and subsegments:

APIs Market, by Type

  • Metallic Biomaterials
    • Stainless Steel
    • Titanium & Titanium Alloys
    • Cobalt-Chrome Alloys
    • Gold
    • Silver
    • Magnesium
  • Polymeric Biomaterials
    • Polymethylmethacrylate
    • Polyethylene
    • Polyester
    • Silicone Rubber
    • Nylon
    • Polyetheretherketone
    • Other Polymeric Biomaterials
  • Ceramics
    • Calcium Phosphate
    • Zirconia
    • Aluminum Oxide
    • Calcium Sulfate
    • Carbon
    • Glass
  • Natural Biomaterials
    • Hyaluronic Acid
    • Collagen
    • Gelatin
    • Fibrin
    • Cellulose
    • Chitin
    • Alginates
    • Silk

Biomaterials Market, by Application

  • Cardiovascular
    • Catheters
    • Stents
    • Implantable Cardiac Defibrillators
    • Pacemakers
    • Sensors
    • Heart Valves
    • Vascular Grafts
    • Guidewires
    • Others
  • Orthopedic
    • Joint Replacement
      • Knee Replacement
      • Hip Replacement
      • Shoulder Replacement
      • Others
    • Viscosupplementation
    • Bioresorbable Tissue Fixation
      • Suture Anchors
      • Interference Screws
      • Meniscal Repair Tacks
      • Meshes
    • Spine
      • Spinal Fusion Surgeries
      • Minimally Invasive Fusion Surgeries
      • Motion Preservation & Dynamic Stabilization Surgeries
        • Pedicle-Based Rod Systems
        • Interspinous Spacers
        • Artificial Discs
    • Fracture Fixation Devices
      • Bone Plates
      • Screws
      • Pins
      • Rods
      • Wires
    • Synthetics Bone Grafts
  • Ophthalmology
    • Contact Lenses
      • Intraocular Lenses
      • Functional Replacement of Ocular Tissues
      • Synthetic Corneas
      • Others
  • Dental
    • Dental Implants
    • Dental Bone Grafts & Substitutes
    • Dental Membranes
    • Tissue Regeneration
  • Plastic Surgery
    • Soft-Tissue Fillers
    • Craniofacial Surgery
  • Wound Healing
    • Wound Closure Devices
      • Sutures
      • Staples
    • Surgical Hemostats
    • Internal Tissue Sealants
    • Adhesion Barriers
    • Hernia Meshes
  • Tissue Engineering
    • Scaffolds for Regenerative Medicine
    • Nanomaterials for Biosensing
    • Tailoring of Inorganic Nanoparticles
  • Neurological/Central Nervous System Applications
    • Shunting Systems
    • Cortical Neural Prosthetics
    • Hydrogel Scaffolds for CNS Repair
    • Neural Stem Cell Encapsulation
  • Other Applications
    • Drug Delivery Systems
    • Gastrointestinal Applications
    • Bariatric Surgery
    • Urinary Applications

Biomaterials Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Rest of the World (RoW)

Recent Developments

  • In 2019, Royal DSM (Netherlands) and ProMed Pharma (US) partnered for the development of novel sustained release drug delivery solutions in the polymeric drug delivery area.
  • In 2018, Covestro AG (Germany) signed an MoU with a group of ten companies and two research organizations with an aim to build a Composite Application Center (CAC) in Singapore. This was aimed to develop end-to-end solutions for advanced composites, such as thermoplastic materials.
  • In 2019, Celanese Corporation (US) announced an expansion of its production facility of thermoplastic co-polyesters. This expansion is expected to support the demand of its global engineered

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 31)
    1.1 OBJECTIVES OF STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
                    FIGURE 1 GLOBAL BIOMATERIALS MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA
           FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                               FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS
    2.2 MARKET SIZE ESTIMATION
           FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
           FIGURE 6 MARKET SIZE ESTIMATION: BIOMATERIALS MARKET
           FIGURE 7 SEGMENTAL ASSESSMENT: BIOMATERIALS MARKET
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 44)
    FIGURE 9 BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION)
    FIGURE 10 METALLIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION)
    FIGURE 11 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION)
    FIGURE 12 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION)
    FIGURE 13 NATURAL BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION)
    FIGURE 14 CARDIOVASCULAR APPLICATIONS DOMINATED THE BIOMATERIALS MARKET IN 2019
    FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE BIOMATERIALS MARKET

4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 BIOMATERIALS MARKET OVERVIEW
           FIGURE 16 INCREASING DEMAND FOR IMPLANTABLE DEVICES TO DRIVE THE GROWTH OF THE MARKET
    4.2 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE & COUNTRY (2019)
           FIGURE 17 METALLIC BIOMATERIALS TO DOMINATE THE NORTH AMERICAN BIOMATERIALS MARKET IN 2019
    4.3 METALLIC BIOMATERIALS MARKET, BY TYPE
           FIGURE 18 TITANIUM & TITANIUM ALLOYS ARE PROJECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 53)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 19 BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS
           5.2.1 DRIVERS
                    5.2.1.1 Increased funds and grants by government bodies and universities for the development of novel biomaterials
                    5.2.1.2 Increasing demand for implantable devices
                    5.2.1.3 Growing demand for biomaterials in plastic surgery and wound healing applications
                    5.2.1.4 Rising incidence of cardiovascular diseases
                    5.2.1.5 Increasing research on regenerative medicine
           5.2.2 RESTRAINTS
                    5.2.2.1 Stringent clinical & regulatory processes
                    5.2.2.2 Unfavorable healthcare reforms in the US
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing healthcare market in emerging economies
                    5.2.3.2 Increasing number of free-trade agreements
           5.2.4 CHALLENGES
                    5.2.4.1 Limitations of biomaterial-based products
                    5.2.4.2 Shortage of skilled surgeons
           5.2.5 TRENDS
                    5.2.5.1 Impact of COVID-19 on the biomaterials market

6 REGULATORY ASSESSMENT (Page No. - 61)
    6.1 INTRODUCTION
    6.2 US
           6.2.1 INTRODUCTION
           6.2.2 FDA DEVICE CLASSIFICATION
                    FIGURE 20 US: REGULATORY APPROVAL PROCESS
           6.2.3 US: REGULATORY APPROVAL TIMELINE ASSESSMENT
                    FIGURE 21 REGULATORY APPROVAL TIMELINE IN THE US
           6.2.4 STRINGENT FDA REGULATIONS GOVERNING PRODUCT APPROVALS
    6.3 CANADA
           6.3.1 INTRODUCTION
                    FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS
           6.3.2 CANADA: REGULATORY APPROVAL TIMELINE ASSESSMENT
                    FIGURE 23 REGULATORY APPROVAL TIMELINE IN CANADA
           6.3.3 HEALTH CANADA CLASSIFICATION
    6.4 EUROPE
           6.4.1 INTRODUCTION
           6.4.2 EUROPEAN MEDICAL DEVICE CLASSIFICATION
                    FIGURE 24 EUROPE: REGULATORY APPROVAL PROCESS
           6.4.3 EUROPE: REGULATORY APPROVAL TIMELINE ASSESSMENT
                    FIGURE 25 REGULATORY APPROVAL TIMELINE IN EUROPE
           6.4.4 EUROPEAN REGULATORY PROCESS TO GET MORE STRINGENT IN FUTURE
    6.5 JAPAN
           6.5.1 INTRODUCTION
           6.5.2 PMDA DEVICE CLASSIFICATION
                    FIGURE 26 JAPAN: REGULATORY APPROVAL PROCESS
           6.5.3 JAPAN: REGULATORY APPROVAL TIMELINE ASSESSMENT
                    FIGURE 27 REGULATORY APPROVAL TIMELINE IN JAPAN
           6.5.4 REVISION OF THE PHARMACEUTICAL AFFAIRS LAW (PAL) AND IMPLEMENTATION OF THE NEW PMD ACT IN JAPAN
    6.6 CHINA
           6.6.1 INTRODUCTION
           6.6.2 CFDA DEVICE CLASSIFICATION
                    FIGURE 28 CHINA: REGULATORY APPROVAL PROCESS
           6.6.3 CHINA: REGULATORY APPROVAL TIMELINE ASSESSMENT
                    FIGURE 29 REGULATORY APPROVAL TIMELINE IN CHINA
           6.6.4 RISING HURDLES IN THE REGULATORY PROCESS IN CHINA
    6.7 INDIA
           6.7.1 INTRODUCTION
                    FIGURE 30 INDIA: REGULATORY APPROVAL PROCESS
           6.7.2 INDIAN MEDICAL DEVICES CLASSIFICATION
    6.8 AUSTRALIA
           6.8.1 INTRODUCTION
           6.8.2 TGA DEVICE CLASSIFICATION
                    FIGURE 31 AUSTRALIA: REGULATORY APPROVAL PROCESS
           6.8.3 AUSTRALIA: REGULATORY APPROVAL TIMELINE ASSESSMENT
                    FIGURE 32 REGULATORY APPROVAL TIMELINE IN AUSTRALIA

7 BIOMATERIALS MARKET, BY TYPE (Page No. - 82)
    7.1 INTRODUCTION
           TABLE 1 IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION
           TABLE 2 BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 3 BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
    7.2 METALLIC BIOMATERIALS
           TABLE 4 METALLIC BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 5 METALLIC BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 6 METALLIC BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 7 METALLIC BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.2.1 STAINLESS STEEL
                    7.2.1.1 Stainless steel dominates the metallic biomaterials market
                               TABLE 8 STAINLESS STEEL BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 9 STAINLESS STEEL BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.2.2 TITANIUM & TITANIUM ALLOYS
                    7.2.2.1 Growing number of joint replacement procedures will drive the market for titanium biomaterials
                               TABLE 10 TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 11 TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.2.3 COBALT-CHROME ALLOYS
                    7.2.3.1 Low cost and excellent corrosion resistance have driven the use of cobalt-chrome alloys
                               TABLE 12 COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 13 COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.2.4 GOLD
                    7.2.4.1 Expanding applications of gold nanoparticles to drive the demand for gold biomaterials
                               TABLE 14 GOLD BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 15 GOLD BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.2.5 SILVER
                    7.2.5.1 Toxic properties and low aesthetic appeal likely to limit the use of silver in biomaterial-based products
                               TABLE 16 SILVER BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 17 SILVER BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.2.6 MAGNESIUM
                    7.2.6.1 Biodegradable characteristic of magnesium stimulates the growth of this market segment
                               TABLE 18 MAGNESIUM BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 19 MAGNESIUM BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
    7.3 POLYMERIC BIOMATERIALS
           TABLE 20 APPLICATIONS OF SYNTHETIC POLYMERS
           TABLE 21 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 22 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 23 POLYMERIC BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 24 POLYMERIC BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.3.1 POLYMETHYLMETHACRYLATE (PMMA)
                    7.3.1.1 PMMA dominates the polymeric biomaterials market
                               TABLE 25 POLYMETHYLMETHACRYLATE BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 26 POLYMETHYLMETHACRYLATE BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.3.2 POLYETHYLENE
                    7.3.2.1 Wear and tear resistance of polyethylene has made it popular in hip and knee joint replacements
                               TABLE 27 POLYETHYLENE BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 28 POLYETHYLENE BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.3.3 POLYESTER
                    7.3.3.1 Biodegradable nature and biocompatibility of polyester will drive its use in various medical applications
                               TABLE 29 POLYESTER BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 30 POLYESTER BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.3.4 POLYVINYLCHLORIDE
                    7.3.4.1 Heavy chlorine content of PVC is likely to hamper the market growth
                               TABLE 31 POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 32 POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.3.5 SILICONE RUBBER
                    7.3.5.1 Silicone rubbers are non-reactive, stable, and resistant to extreme environments and temperatures
                               TABLE 33 SILICONE RUBBER BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 34 SILICONE RUBBER BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.3.6 NYLON
                    7.3.6.1 Low weight, corrosion resistance, and wide applications of nylon are expected to drive the market demand
                               TABLE 35 NYLON BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 36 NYLON BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.3.7 POLYETHERETHERKETONE
                    7.3.7.1 PEEK is gaining popularity as a viable alternative to metals
                               TABLE 37 POLYETHERETHERKETONE BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 38 POLYETHERETHERKETONE BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.3.8 OTHER POLYMERIC BIOMATERIALS
                    TABLE 39 OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 40 OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
    7.4 CERAMIC BIOMATERIALS
           TABLE 41 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 42 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 43 CERAMIC BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 44 CERAMIC BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.4.1 CALCIUM PHOSPHATE
                    7.4.1.1 Calcium phosphate is the largest segment in the ceramic biomaterials market
                               TABLE 45 CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 46 CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.4.2 ZIRCONIA
                    7.4.2.1 Bio-inertness and low wear rate of zirconia will boost the market growth
                               TABLE 47 ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 48 ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.4.3 ALUMINUM OXIDE
                    7.4.3.1 Increasing use of aluminum oxide in hip replacements and dental implants to drive the market
                               TABLE 49 ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 50 ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.4.4 CALCIUM SULFATE
                    7.4.4.1 Fast resorption rate of calcium sulfate is likely to hamper its use
                               TABLE 51 CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 52 CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.4.5 CARBON
                    7.4.5.1 Increasing use of carbon nanofibers in regenerative medicine and cancer treatment will drive market growth
                               TABLE 53 CARBON BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 54 CARBON BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.4.6 GLASS
                    7.4.6.1 Rising number of orthopedic and dental procedures is likely to drive the demand for glass biomaterials
                               TABLE 55 GLASS BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 56 GLASS BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
    7.5 NATURAL BIOMATERIALS
           TABLE 57 APPLICATIONS OF NATURAL BIOMATERIALS
           TABLE 58 NATURAL BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 59 NATURAL BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 60 NATURAL BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 61 NATURAL BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.5.1 HYALURONIC ACID
                    7.5.1.1 Rising prevalence of osteoarthritis to drive the hyaluronic acid market
                               TABLE 62 HYALURONIC ACID BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 63 HYALURONIC ACID BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.5.2 COLLAGEN
                    7.5.2.1 Rising prevalence of target applications to drive growth in the collagen market
                               TABLE 64 COLLAGEN BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 65 COLLAGEN BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.5.3 GELATIN
                    7.5.3.1 Low cost of gelatin to drive its market growth
                               TABLE 66 GELATIN BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 67 GELATIN BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.5.4 FIBRIN
                    7.5.4.1 Fibrin biomaterials were among the first used to prevent bleeding
                               TABLE 68 FIBRIN BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 69 FIBRIN BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.5.5 CELLULOSE
                    7.5.5.1 Cellulose finds applications in wound healing, skin regeneration, and ophthalmology
                               TABLE 70 CELLULOSE BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 71 CELLULOSE BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.5.6 CHITIN
                    7.5.6.1 Chitin accelerates skin regeneration and possesses high biocompatibility
                               TABLE 72 CHITIN BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 73 CHITIN BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.5.7 ALGINATES
                    7.5.7.1 Various applications of alginates include wound healing, tissue engineering & regenerative medicine, and drug delivery
                               TABLE 74 ALGINATE BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 75 ALGINATE BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           7.5.8 SILK
                    7.5.8.1 Flexibility, glossiness, and adhesive abilities of silk have made it popular in cosmetic applications
                               TABLE 76 SILK BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 77 SILK BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)

8 BIOMATERIALS MARKET, BY APPLICATION (Page No. - 119)
    8.1 INTRODUCTION
           TABLE 78 BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
           TABLE 79 BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
    8.2 CARDIOVASCULAR
           TABLE 80 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY PRODUCT, 2016–2019 (USD MILLION)
           TABLE 81 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY PRODUCT, 2020–2025 (USD MILLION)
           TABLE 82 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
           TABLE 83 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)
           8.2.1 CATHETERS
                    8.2.1.1 Shift in patient preference from traditional open surgeries to minimally invasive surgeries to drive the catheters market
                               TABLE 84 BIOMATERIALS MARKET FOR CATHETERS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 85 BIOMATERIALS MARKET FOR CATHETERS, BY REGION, 2020–2025 (USD MILLION)
           8.2.2 STENTS
                    8.2.2.1 Increasing number of coronary intervention procedures to boost the demand for implantable stents
                               TABLE 86 BIOMATERIALS MARKET FOR STENTS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 87 BIOMATERIALS MARKET FOR STENTS, BY REGION, 2020–2025 (USD MILLION)
           8.2.3 IMPLANTABLE CARDIAC DEFIBRILLATORS
                    8.2.3.1 Growing geriatric population is expected to increase the demand for implantable cardiac defibrillators
                               TABLE 88 BIOMATERIALS MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 89 BIOMATERIALS MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2020–2025 (USD MILLION)
           8.2.4 PACEMAKERS
                    8.2.4.1 High prevalence of bradycardia is increasing the demand for pacemakers
                               TABLE 90 BIOMATERIALS MARKET FOR PACEMAKERS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 91 BIOMATERIALS MARKET FOR PACEMAKERS, BY REGION, 2020–2025 (USD MILLION)
           8.2.5 SENSORS
                    8.2.5.1 Increasing prevalence of cardiac disorders is boosting the demand for cardiovascular sensors
                               TABLE 92 BIOMATERIALS MARKET FOR SENSORS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 93 BIOMATERIALS MARKET FOR SENSORS, BY REGION, 2020–2025 (USD MILLION)
           8.2.6 HEART VALVES
                    8.2.6.1 Growing geriatric population is set to increase the demand for prosthetic valves
                               TABLE 94 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS
                               TABLE 95 BIOMATERIALS MARKET FOR HEART VALVES, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 96 BIOMATERIALS MARKET FOR HEART VALVES, BY REGION, 2020–2025 (USD MILLION)
           8.2.7 VASCULAR GRAFTS
                    8.2.7.1 Various research studies related to the use of biomaterials in vascular grafts will open opportunities for growth of the market
                               TABLE 97 BIOMATERIALS MARKET FOR VASCULAR GRAFTS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 98 BIOMATERIALS MARKET FOR VASCULAR GRAFTS, BY REGION, 2020–2025 (USD MILLION)
           8.2.8 GUIDEWIRES
                    8.2.8.1 Guidewires are widely used for guiding catheters and placing stents inside the heart
                               TABLE 99 BIOMATERIALS MARKET FOR GUIDEWIRES, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 100 BIOMATERIALS MARKET FOR GUIDEWIRES, BY REGION, 2020–2025 (USD MILLION)
           8.2.9 OTHER PRODUCTS
                    TABLE 101 BIOMATERIALS MARKET FOR OTHER PRODUCTS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 102 BIOMATERIALS MARKET FOR OTHER PRODUCTS, BY REGION, 2020–2025 (USD MILLION)
    8.3 ORTHOPEDIC
           TABLE 103 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 104 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 105 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
           TABLE 106 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)
           8.3.1 JOINT REPLACEMENT
                    TABLE 107 JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                    TABLE 108 JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                    TABLE 109 JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 110 JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
                    8.3.1.1 Knee replacement
                               8.3.1.1.1 Increasing number of knee replacement procedures across the globe to drive market growth
                                             TABLE 111 KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 112 KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
                    8.3.1.2 Hip replacement
                               8.3.1.2.1 Hip and knee joint replacements are the most commonly performed procedures in the US—a key factor driving growth
                                             TABLE 113 HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 114 HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
                    8.3.1.3 Shoulder replacement
                               8.3.1.3.1 Shoulder replacement is the most common joint replacement surgery conducted globally
                                             TABLE 115 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 116 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
                    8.3.1.4 Other joint replacement applications
                               TABLE 117 OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 118 OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           8.3.2 VISCOSUPPLEMENTATION
                    8.3.2.1 Rising cases of osteoarthritis will drive growth in the viscosupplementation market
                               TABLE 119 VISCOSUPPLEMENTATION BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 120 VISCOSUPPLEMENTATION BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           8.3.3 BIORESORBABLE TISSUE FIXATION
                    TABLE 121 BIORESORBABLE BIOMATERIALS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                    TABLE 122 BIORESORBABLE BIOMATERIALS MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
                    TABLE 123 BIORESORBABLE BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 124 BIORESORBABLE BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
                    8.3.3.1 Suture anchors
                               8.3.3.1.1 Growing awareness about suture anchor devices will drive market growth
                                             TABLE 125 BIOMATERIALS MARKET FOR SUTURE ANCHORS, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 126 BIOMATERIALS MARKET FOR SUTURE ANCHORS, BY REGION, 2020–2025 (USD MILLION)
                    8.3.3.2 Interference screws
                               8.3.3.2.1 Increasing awareness about ACL will contribute to market growth
                                             TABLE 127 BIOMATERIALS MARKET FOR INTERFERENCE SCREWS, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 128 BIOMATERIALS MARKET FOR INTERFERENCE SCREWS, BY REGION, 2020–2025 (USD MILLION)
                    8.3.3.3 Meniscal repair tacks
                               8.3.3.3.1 Rising sports injuries will drive growth in the meniscal repair tacks market
                                             TABLE 129 BIOMATERIALS MARKET FOR MENISCAL REPAIR TACKS, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 130 BIOMATERIALS MARKET FOR MENISCAL REPAIR TACKS, BY REGION, 2020–2025 (USD MILLION)
                    8.3.3.4 Meshes
                               8.3.3.4.1 Wear resistance, proper shaping, and holding capacity of bioresorbable implants increase the demand for bioresorbable meshes
                                             TABLE 131 BIOMATERIALS MARKET FOR MESHES, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 132 BIOMATERIALS MARKET FOR MESHES, BY REGION, 2020–2025 (USD MILLION)
           8.3.4 SPINE
                    TABLE 133 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE, 2016–2019 (USD MILLION)
                    TABLE 134 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE, 2020–2025 (USD MILLION)
                    TABLE 135 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 136 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION, 2020–2025 (USD MILLION)
                    8.3.4.1 Spinal fusion
                               8.3.4.1.1 Introduction of minimally invasive spinal fusion procedures and better clinical outcomes to drive market growth
                                             TABLE 137 BIOMATERIALS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 138 BIOMATERIALS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2020–2025 (USD MILLION)
                    8.3.4.2 Minimally invasive fusion
                               8.3.4.2.1 Advantages such as lesser pain post surgery and faster recovery to drive the demand for minimally invasive fusion procedures
                                             TABLE 139 BIOMATERIALS MARKET FOR MINIMALLY INVASIVE FUSION SURGERIES, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 140 BIOMATERIALS MARKET FOR MINIMALLY INVASIVE FUSION SURGERIES, BY REGION, 2020–2025 (USD MILLION)
                    8.3.4.3 Motion preservation & dynamic stabilization
                                             TABLE 141 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY PRODUCT, 2016–2019 (USD MILLION)
                                             TABLE 142 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY PRODUCT, 2020–2025 (USD MILLION)
                                             TABLE 143 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 144 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY REGION, 2020–2025 (USD MILLION)
                               8.3.4.3.1 Pedicle-based rod systems
                                             8.3.4.3.1.1 Rising geriatric population will result in growth in the pedicle-based rod systems market
                                             TABLE 145 BIOMATERIALS MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 146 BIOMATERIALS MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2020–2025 (USD MILLION)
                               8.3.4.3.2 Interspinous spacers
                                             8.3.4.3.2.1 High prevalence of degenerative spinal conditions will contribute to the growth of the interspinous spacers market
                                             TABLE 147 BIOMATERIALS MARKET FOR INTERSPINOUS SPACERS, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 148 BIOMATERIALS MARKET FOR INTERSPINOUS SPACERS, BY REGION, 2020–2025 (USD MILLION)
                               8.3.4.3.3 Artificial discs
                                             8.3.4.3.3.1 High biocompatibility of biomaterials has led to their increased use in artificial discs
                                             TABLE 149 BIOMATERIALS MARKET FOR ARTIFICIAL DISCS, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 150 BIOMATERIALS MARKET FOR ARTIFICIAL DISCS, BY REGION, 2020–2025 (USD MILLION)
           8.3.5 FRACTURE FIXATION DEVICES
                    TABLE 151 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY TYPE, 2016–2019 (USD MILLION)
                    TABLE 152 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY TYPE, 2020–2025 (USD MILLION)
                    TABLE 153 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 154 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY REGION, 2020–2025 (USD MILLION)
                    8.3.5.1 Bone plates
                               8.3.5.1.1 Biomaterials form an integral component of bone plates due to their high biocompatibility
                                             TABLE 155 BIOMATERIALS MARKET FOR BONE PLATES, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 156 BIOMATERIALS MARKET FOR BONE PLATES, BY REGION, 2020–2025 (USD MILLION)
                    8.3.5.2 Screws
                               8.3.5.2.1 Screws made up of biomaterials such as stainless steel, titanium, and cobalt are extensively used in orthopedic procedures
                                             TABLE 157 BIOMATERIALS MARKET FOR SCREWS, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 158 BIOMATERIALS MARKET FOR SCREWS, BY REGION, 2020–2025 (USD MILLION)
                    8.3.5.3 Pins
                               8.3.5.3.1 Nonreactive metallic biomaterials such as stainless steel, titanium, and cobalt are majorly used to manufacture pins
                                             TABLE 159 BIOMATERIALS MARKET FOR PINS, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 160 BIOMATERIALS MARKET FOR PINS, BY REGION, 2020–2025 (USD MILLION)
                    8.3.5.4 Rods
                               8.3.5.4.1 Rods are preferred for fracture fixation procedures due to their high rigidity, easy mobility, and cost efficiency
                                             TABLE 161 BIOMATERIALS MARKET FOR RODS, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 162 BIOMATERIALS MARKET FOR RODS, BY REGION, 2020–2025 (USD MILLION)
                    8.3.5.5 Wires
                               8.3.5.5.1 Wires made up of metallic biomaterials are widely used to treat fractures of small bones
                                             TABLE 163 BIOMATERIALS MARKET FOR WIRES, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 164 BIOMATERIALS MARKET FOR WIRES, BY REGION, 2020–2025 (USD MILLION)
           8.3.6 SYNTHETICS BONE GRAFTS
                    8.3.6.1 Growing geriatric population and increasing incidence of sports-related injuries are driving the market for synthetic bone grafts
                               TABLE 165 BIOMATERIALS MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 166 BIOMATERIALS MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION, 2020–2025 (USD MILLION)
    8.4 OPHTHALMOLOGY
           TABLE 167 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 168 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 169 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
           TABLE 170 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)
           8.4.1 CONTACT LENSES
                    8.4.1.1 High cases of refractive errors and preference for contact lenses over spectacles to drive the market for contact lenses
                               TABLE 171 BIOMATERIALS MARKET FOR CONTACT LENSES, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 172 BIOMATERIALS MARKET FOR CONTACT LENSES, BY REGION, 2020–2025 (USD MILLION)
           8.4.2 INTRAOCULAR LENSES
                    8.4.2.1 Increasing prevalence of cataracts to drive the number of cataract surgeries performed
                               TABLE 173 BIOMATERIALS MARKET FOR INTRAOCULAR LENSES, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 174 BIOMATERIALS MARKET FOR INTRAOCULAR LENSES, BY REGION, 2020–2025 (USD MILLION)
           8.4.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
                    8.4.3.1 Increasing funding and research activities for developing bionic eyes are driving the market for this application
                               TABLE 175 BIOMATERIALS MARKET FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 176 BIOMATERIALS MARKET FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, BY REGION, 2020–2025 (USD MILLION)
           8.4.4 SYNTHETIC CORNEAS
                    8.4.4.1 Growing number of corneal blindness cases worldwide to boost the demand for synthetic collagen biomaterials
                               TABLE 177 BIOMATERIALS MARKET FOR SYNTHETIC CORNEAS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 178 BIOMATERIALS MARKET FOR SYNTHETIC CORNEAS, BY REGION, 2020–2025 (USD MILLION)
           8.4.5 OTHER OPHTHALMOLOGY APPLICATIONS
                    TABLE 179 BIOMATERIALS MARKET FOR OTHER OPHTHALMOLOGY APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 180 BIOMATERIALS MARKET FOR OTHER OPHTHALMOLOGY APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)
    8.5 DENTAL
           TABLE 181 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY PRODUCT, 2016–2019 (USD MILLION)
           TABLE 182 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY PRODUCT, 2020–2025 (USD MILLION)
           TABLE 183 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
           TABLE 184 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)
           8.5.1 DENTAL IMPLANTS
                    8.5.1.1 Increasing awareness of dental services and improving quality of dental products are driving the growth of this market segment
                               TABLE 185 PERCENTAGE OF INDIVIDUALS WITH UNTREATED DENTAL CARIES IN THE US (2016)
                               TABLE 186 BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 187 BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY REGION, 2020–2025 (USD MILLION)
           8.5.2 DENTAL BONE GRAFTS & SUBSTITUTES
                    8.5.2.1 Growing demand for dental implants among people opting for cosmetic dentistry to drive market growth
                               TABLE 188 BIOMATERIALS MARKET FOR DENTAL BONE GRAFTS & SUBSTITUTES, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 189 BIOMATERIALS MARKET FOR DENTAL BONE GRAFTS & SUBSTITUTES, BY REGION, 2020–2025 (USD MILLION)
           8.5.3 DENTAL MEMBRANES
                    8.5.3.1 Dental membranes are widely used in oral and periodontal surgery to prevent unwanted infections in the oral cavity
                               TABLE 190 BIOMATERIALS MARKET FOR DENTAL MEMBRANES, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 191 BIOMATERIALS MARKET FOR DENTAL MEMBRANES, BY REGION, 2020–2025 (USD MILLION)
           8.5.4 TISSUE REGENERATION MATERIALS
                    8.5.4.1 Increasing prevalence of periodontal disease is driving the market for biomaterials in this particular application
                               TABLE 192 BIOMATERIALS MARKET FOR TISSUE REGENERATION, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 193 BIOMATERIALS MARKET FOR TISSUE REGENERATION, BY REGION, 2020–2025 (USD MILLION)
    8.6 PLASTIC SURGERY
           TABLE 194 BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY APPLICATION, 2016–2019 (USD MILLION)
           TABLE 195 BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY APPLICATION, 2020–2025 (USD MILLION)
           TABLE 196 BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY REGION, 2016–2019 (USD MILLION)
           TABLE 197 BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY REGION, 2020–2025 (USD MILLION)
           8.6.1 SOFT-TISSUE FILLERS
                    8.6.1.1 Advantages such as long-lasting capacity and less allergic reactions to drive the demand for soft-tissue fillers
                               TABLE 198 BIOMATERIALS MARKET FOR SOFT-TISSUE FILLERS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 199 BIOMATERIALS MARKET FOR SOFT-TISSUE FILLERS, BY REGION, 2020–2025 (USD MILLION)
           8.6.2 CRANIOFACIAL SURGERY
                    8.6.2.1 Increasing incidence of trauma cases and head & neck cancer to increase the number of craniofacial surgeries
                               TABLE 200 BIOMATERIALS MARKET FOR CRANIOFACIAL SURGERY, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 201 BIOMATERIALS MARKET FOR CRANIOFACIAL SURGERY, BY REGION, 2020–2025 (USD MILLION)
    8.7 WOUND HEALING
           TABLE 202 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2016–2019 (USD MILLION)
           TABLE 203 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2020–2025 (USD MILLION)
           TABLE 204 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
           TABLE 205 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)
           8.7.1 WOUND CLOSURE DEVICES
                    TABLE 206 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY PRODUCT, 2016–2019 (USD MILLION)
                    TABLE 207 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY PRODUCT, 2020–2025 (USD MILLION)
                    TABLE 208 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 209 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY REGION, 2020–2025 (USD MILLION)
                    8.7.1.1 Sutures
                               8.7.1.1.1 Sutures can be used as advanced biologically active components enabling the delivery of drugs
                                             TABLE 210 BIOMATERIALS MARKET FOR SUTURES, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 211 BIOMATERIALS MARKET FOR SUTURES, BY REGION, 2020–2025 (USD MILLION)
                    8.7.1.2 Staples
                               8.7.1.2.1 Staples are easy to place and can shorten the closure by 70–80% compared to sutures
                                             TABLE 212 BIOMATERIALS MARKET FOR STAPLES, BY REGION, 2016–2019 (USD MILLION)
                                             TABLE 213 BIOMATERIALS MARKET FOR STAPLES, BY REGION, 2020–2025 (USD MILLION)
           8.7.2 SURGICAL HEMOSTATS
                    8.7.2.1 Surgical hemostats have the ability to control bleeding and reduce the need for frequent blood transfusions during surgical procedures
                               TABLE 214 BIOMATERIALS MARKET FOR SURGICAL HEMOSTATS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 215 BIOMATERIALS MARKET FOR SURGICAL HEMOSTATS, BY REGION, 2020–2025 (USD MILLION)
           8.7.3 INTERNAL TISSUE SEALANTS
                    8.7.3.1 Internal tissue sealants are made of biomaterials such as fibrin, gelatin, thrombin, synthetic polymers, and biosynthetic polymers
                               TABLE 216 BIOMATERIALS MARKET FOR INTERNAL TISSUE SEALANTS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 217 BIOMATERIALS MARKET FOR INTERNAL TISSUE SEALANTS, BY REGION, 2020–2025 (USD MILLION)
           8.7.4 ADHESION BARRIERS
                    8.7.4.1 Biomaterials such as Teflon sheets, animal membranes, gold foil, silk, and rubber are used as adhesion barriers
                               TABLE 218 BIOMATERIALS MARKET FOR ADHESION BARRIERS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 219 BIOMATERIALS MARKET FOR ADHESION BARRIERS, BY REGION, 2020–2025 (USD MILLION)
           8.7.5 HERNIA MESHES
                    8.7.5.1 Meshes used in hernia repair are mainly made up of polymeric biomaterials
                               TABLE 220 BIOMATERIALS MARKET FOR HERNIA MESHES, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 221 BIOMATERIALS MARKET FOR HERNIA MESHES, BY REGION, 2020–2025 (USD MILLION)
    8.8 TISSUE ENGINEERING
           TABLE 222 TISSUE ENGINEERING BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
           TABLE 223 TISSUE ENGINEERING BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           TABLE 224 TISSUE ENGINEERING BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 225 TISSUE ENGINEERING BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           8.8.1 SCAFFOLDS FOR REGENERATIVE MEDICINE
                    8.8.1.1 Rise in organ transplantation procedures to drive the market
                               TABLE 226 TISSUE ENGINEERING BIOMATERIALS MARKET FOR SCAFFOLDS FOR REGENERATIVE MEDICINE, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 227 TISSUE ENGINEERING BIOMATERIALS MARKET FOR SCAFFOLDS FOR REGENERATIVE MEDICINE, BY REGION, 2020–2025 (USD MILLION)
           8.8.2 NANOMATERIALS FOR BIOSENSING
                    8.8.2.1 Growth in this segment will be driven by rising research in the field of nanotechnology
                               TABLE 228 TISSUE ENGINEERING BIOMATERIALS MARKET FOR NANOMATERIALS FOR BIOSENSING, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 229 TISSUE ENGINEERING BIOMATERIALS MARKET FOR NANOMATERIALS FOR BIOSENSING, BY REGION, 2020–2025 (USD MILLION)
           8.8.3 TAILORING OF INORGANIC NANOPARTICLES
                    8.8.3.1 Growing demand for nanotechnological medical products will be a key factor in driving the growth of this market
                               TABLE 230 TISSUE ENGINEERING BIOMATERIALS MARKET FOR TAILORING OF INORGANIC NANOPARTICLES, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 231 TISSUE ENGINEERING BIOMATERIALS MARKET FOR TAILORING OF INORGANIC NANOPARTICLES, BY REGION, 2020–2025 (USD MILLION)
    8.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS
           TABLE 232 BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY PRODUCT, 2016–2019 (USD MILLION)
           TABLE 233 BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY PRODUCT, 2020–2025 (USD MILLION)
           TABLE 234 BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
           TABLE 235 BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)
           8.9.1 SHUNTING SYSTEMS
                    8.9.1.1 Rising cases of hydrocephalus will boost the market growth
                               TABLE 236 BIOMATERIALS MARKET FOR SHUNTING SYSTEMS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 237 BIOMATERIALS MARKET FOR SHUNTING SYSTEMS, BY REGION, 2020–2025 (USD MILLION)
           8.9.2 CORTICAL NEURAL PROSTHETICS
                    8.9.2.1 Polymer-coated CNPs are relatively new in the market and are mainly used to treat paralyzed patients
                               TABLE 238 BIOMATERIALS MARKET FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 239 BIOMATERIALS MARKET FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2020–2025 (USD MILLION)
           8.9.3 HYDROGEL SCAFFOLDS FOR CNS REPAIR
                    8.9.3.1 With increasing incidence of spinal cord surgeries, the demand for hydrogel scaffolds is expected to grow in the coming years
                               TABLE 240 BIOMATERIALS MARKET FOR HYDROGEL SCAFFOLDS FOR CNS REPAIR, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 241 BIOMATERIALS MARKET FOR HYDROGEL SCAFFOLDS FOR CNS REPAIR, BY REGION, 2020–2025 (USD MILLION)
           8.9.4 NEURAL STEM CELL ENCAPSULATION
                    8.9.4.1 Lack of substitutes for the treatment of neurotrauma is boosting the market growth
                               TABLE 242 BIOMATERIALS MARKET FOR NEURAL STEM CELL ENCAPSULATION, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 243 BIOMATERIALS MARKET FOR NEURAL STEM CELL ENCAPSULATION, BY REGION, 2020–2025 (USD MILLION)
    8.10 OTHER APPLICATIONS
           TABLE 244 OTHER BIOMATERIAL APPLICATIONS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 245 OTHER BIOMATERIAL APPLICATIONS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 246 OTHER BIOMATERIAL APPLICATIONS MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 247 OTHER BIOMATERIAL APPLICATIONS MARKET, BY REGION, 2020–2025 (USD MILLION)
           8.10.1 DRUG DELIVERY SYSTEMS
                    TABLE 248 BIOMATERIALS MARKET FOR DRUG DELIVERY SYSTEMS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 249 BIOMATERIALS MARKET FOR DRUG DELIVERY SYSTEMS, BY REGION, 2020–2025 (USD MILLION)
           8.10.2 GASTROINTESTINAL APPLICATIONS
                    TABLE 250 BIOMATERIALS MARKET FOR GASTROINTESTINAL APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 251 BIOMATERIALS MARKET FOR GASTROINTESTINAL APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)
           8.10.3 BARIATRIC SURGERY
                    TABLE 252 BIOMATERIALS MARKET FOR BARIATRIC SURGERY, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 253 BIOMATERIALS MARKET FOR BARIATRIC SURGERY, BY REGION, 2020–2025 (USD MILLION)
           8.10.4 URINARY APPLICATIONS
                    TABLE 254 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 255 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)

9 BIOMATERIALS MARKET, BY REGION (Page No. - 204)
    9.1 INTRODUCTION
           TABLE 256 BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 257 BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION)
           FIGURE 33 BIOMATERIALS MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
    9.2 NORTH AMERICA
           FIGURE 34 NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT
           TABLE 258 NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
           TABLE 259 NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
           TABLE 260 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 261 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 262 NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
           TABLE 263 NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           9.2.1 US
                    9.2.1.1 US dominates the North American biomaterials market
                               TABLE 264 US: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 265 US: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 266 US: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                               TABLE 267 US: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Increasing incidence of cardiovascular diseases to drive market growth in Canada
                               TABLE 268 CANADA: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 269 CANADA: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 270 CANADA: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                               TABLE 271 CANADA: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
    9.3 EUROPE
           TABLE 272 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
           TABLE 273 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
           TABLE 274 EUROPE: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 275 EUROPE: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 276 EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
           TABLE 277 EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Large medical device market to support the adoption of biomaterials in Germany
                               TABLE 278 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 279 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 280 GERMANY: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                               TABLE 281 GERMANY: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Availability of funds and the increasing number of cardiovascular procedures to drive the biomaterials market in the UK
                               TABLE 282 UK: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 283 UK: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 284 UK: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                               TABLE 285 UK: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Rising aging population and associated diseases to drive the market in France
                               TABLE 286 FRANCE: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 287 FRANCE: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 288 FRANCE: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                               TABLE 289 FRANCE: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           9.3.4 SPAIN
                    9.3.4.1 Increasing research activities on biomaterials to drive growth in Spain
                               TABLE 290 SPAIN: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 291 SPAIN: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 292 SPAIN: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                               TABLE 293 SPAIN: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           9.3.5 REST OF EUROPE (ROE)
                    TABLE 294 ROE: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                    TABLE 295 ROE: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                    TABLE 296 ROE: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                    TABLE 297 ROE: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
    9.4 ASIA PACIFIC
           FIGURE 35 ASIA PACIFIC: BIOMATERIALS MARKET SNAPSHOT
           TABLE 298 APAC: BIOMATERIALS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
           TABLE 299 APAC: BIOMATERIALS MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
           TABLE 300 APAC: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 301 APAC: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 302 APAC: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
           TABLE 303 APAC: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           9.4.1 JAPAN
                    9.4.1.1 Growing medical devices industry to drive market growth
                               TABLE 304 JAPAN: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 305 JAPAN: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 306 JAPAN: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                               TABLE 307 JAPAN: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Lucrative medical devices industry in China to drive market growth
                               TABLE 308 CHINA: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 309 CHINA: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 310 CHINA: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                               TABLE 311 CHINA: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Large population base and growing medical tourism in India to drive the growth of the biomaterials market
                               TABLE 312 INDIA: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                               TABLE 313 INDIA: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                               TABLE 314 INDIA: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                               TABLE 315 INDIA: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC (ROAPAC)
                    TABLE 316 ROAPAC: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
                    TABLE 317 ROAPAC: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                    TABLE 318 ROAPAC: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
                    TABLE 319 ROAPAC: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
    9.5 REST OF THE WORLD (ROW)
           TABLE 320 ROW: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 321 ROW: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 322 ROW: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
           TABLE 323 ROW: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 240)
     10.1 OVERVIEW
     10.2 MARKET RANKING ANALYSIS
               FIGURE 36 COMPANY RANKING IN THE BIOMATERIALS MARKET, 2019
     10.3 MARKET EVALUATION FRAMEWORK
               TABLE 324 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCHES & EXPANSIONS—THE MAJOR STRATEGIES ADOPTED BY PLAYERS
     10.4 COMPETITIVE SCENARIO
             10.4.1 KEY PRODUCT LAUNCHES
             10.4.2 KEY COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
             10.4.3 KEY ACQUISITIONS
             10.4.4 KEY EXPANSIONS

11 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 244)
     11.1 OVERVIEW
     11.2 GLOBAL BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX
             11.2.1 STARS
             11.2.2 EMERGING LEADERS
             11.2.3 PERVASIVE PLAYERS
             11.2.4 PARTICIPANTS
                       FIGURE 37 GLOBAL BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX, 2019
     11.3 COMPANY PROFILES
(Business overview, Products offered, Recent developments & MnM View)*
             11.3.1 BASF SE
                       FIGURE 38 BASF: COMPANY SNAPSHOT
             11.3.2 COVESTRO AG
                       FIGURE 39 COVESTRO: COMPANY SNAPSHOT
             11.3.3 CELANESE CORPORATION
                       FIGURE 40 CELANESE CORPORATION: COMPANY SNAPSHOT
             11.3.4 CARPENTER TECHNOLOGY CORPORATION
                       FIGURE 41 CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT
             11.3.5 ROYAL DSM
                       FIGURE 42 ROYAL DSM: COMPANY SNAPSHOT
             11.3.6 CORBION
                       FIGURE 43 CORBION: COMPANY SNAPSHOT
             11.3.7 EVONIK INDUSTRIES
                       FIGURE 44 EVONIK INDUSTRIES: COMPANY SNAPSHOT
             11.3.8 VICTREX PLC
                       FIGURE 45 VICTREX PLC: COMPANY SNAPSHOT
             11.3.9 CERAMTEC GMBH
                       FIGURE 46 CERAMTEC GMBH: COMPANY SNAPSHOT
               11.3.10 MITSUBISHI CHEMICAL HOLDINGS CORPORATION (ADVANSOURCE BIOMATERIALS CORP.)
                       FIGURE 47 MITSUBISHI CHEMICAL HOLDINGS CORPORATION: COMPANY SNAPSHOT
               11.3.11 COORSTEK INC.
               11.3.12 BERKELEY ADVANCED BIOMATERIALS
               11.3.13 CAM BIOCERAMICS B.V.
               11.3.14 ZEUS INDUSTRIAL PRODUCTS, INC.
               11.3.15 GELITA AG
               11.3.16 RDI GROUP (COLLAGEN SOLUTIONS PLC)
               11.3.17 RITON BIOMATERIAL CO., LTD.
               11.3.18 ARTOSS, INC.
               11.3.19 NOBEL BIOMATERIALS
               11.3.20 DIMENSION INX

*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.

12 ADJACENT/RELATED MARKETS (Page No. - 277)
     12.1 INTRODUCTION
     12.2 LIMITATIONS
     12.3 MEDICAL CERAMICS MARKET
             12.3.1 MARKET DEFINITION
             12.3.2 MARKET OVERVIEW
             12.3.3 MEDICAL CERAMICS MARKET, BY REGION
                       TABLE 325 MEDICAL CERAMICS MARKET, BY REGION, 2018–2025 (USD MILLION)
                       12.3.3.1 North America
                                   TABLE 326 NORTH AMERICA: MEDICAL CERAMICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                       12.3.3.2 Europe
                                   TABLE 327 EUROPE: MEDICAL CERAMICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                       12.3.3.3 Asia Pacific
                                   TABLE 328 ASIA PACIFIC: MEDICAL CERAMICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                       12.3.3.4 Latin America
                                   TABLE 329 LATIN AMERICA: MEDICAL CERAMICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
     12.4 BONE CEMENT & GLUE MARKET
             12.4.1 MARKET DEFINITION
             12.4.2 MARKET OVERVIEW
             12.4.3 BONE CEMENT & GLUE MARKET, BY REGION
                       TABLE 330 BONE CEMENT & GLUE MARKET, BY REGION, 2015–2022 (USD MILLION)
                       12.4.3.1 North America
                                   TABLE 331 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
                       12.4.3.2 Europe
                                   TABLE 332 EUROPE: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
                       12.4.3.3 Asia Pacific
                                   TABLE 333 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2015–2022 (USD MILLION)

13 APPENDIX (Page No. - 283)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the biomaterials market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the biomaterials market. The secondary sources used for this study include Some of the key secondary sources referred to for this study include Centre for Advanced Materials and Biomaterials Research (CAMBR), Institute of Biomaterial Science, Medical Design Technology Magazine, Centre for Biomedical and Biomaterials Research (CBBR), Institute of Biomaterials, Biomedical Engineering, and Biomaterials Research Center. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Biomaterials Market  Size, and Share

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the biomaterials market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the biomaterials business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global biomaterials market based on the type, application and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, opportunities and trends)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall biomaterials market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, and Rest of the World
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the biomaterials market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Company Information

  • An additional five company profiles
COVID-19

Get in-depth analysis of the COVID-19 impact on the Biomaterials Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Biomaterials Market

Request For Special Pricing
Report Code
BT 1556
Published ON
Jan, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biomaterials Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved